• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Transgenomic Inc

+ Add to Watchlist

TBIO:US

2.9800 USD 0.2702 9.97%

As of 20:10:00 ET on 10/17/2014.

Snapshot for Transgenomic Inc (TBIO)

Open: 2.7399 Day's Range: 2.7399 - 3.0190 Volume: 5,302
Previous Close: 2.7098 52wk Range: 2.6000 - 7.4400 1-Yr Rtn: -54.43%

Stock Chart for TBIO

No chart data available.
  • TBIO:US 2.9800
  • 1D
  • 1M
  • 1Y
2.7098
Interactive TBIO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TBIO

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -2.4900
Est. EPS (USD) (12/2014) -1.9600
Est. PEG Ratio -
Market Cap (M USD) 21.91
Shares Outstanding (M) 7.35
30 Day Average Volume 35,466
Price/Book (mrq) 2.1253
Price/Sale (ttm) 0.8468
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TBIO

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TBIO

Transgenomic, Inc. provides research tools to the life sciences industry. These tools enable researchers to discover and understand variation in the human genetic code, or genome, in order to accelerate and improve drug development and diagnostics.

Paul KinnonPresident/CEOMark P ColonneseExec VP/CFO
More Company Profile & Key Executives for TBIO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil